Research Article

Developmental Biology

Coordination between ECM and cell-cell adhesion regulates the development of islet aggregation, architecture, and functional maturation

Department of Translational Research and Cellular Therapeutics, Arthur Riggs Diabetes and Metabolism Research Institute, Beckman Research Institute, City of Hope, United States
Department of Biomedical Engineering, College of Engineering, California State University, Long Beach, United States
Light Microscopy Core, Beckman Research Institute, City of Hope, United States
Department of Neurobiology, Physiology and Behavior, University of California, Davis, United States
Department of Cellular and Physiological Sciences, Life Sciences Institute, University of British Columbia, Canada
Department of Molecular & Cellular Endocrinology, Arthur Riggs Diabetes and Metabolism Research Institute, Beckman Research Institute, City of Hope, United States
Department of Physiology and Membrane Biology, School of Medicine, University of California, Davis, United States

Aug 23, 2023

https://doi.org/10.7554/eLife.90006

Open access
Copyright information

Version of Record

Accepted for publication after peer review and revision.

Download
Cite
Share
CommentOpen annotations (there are currently 0 annotations on this page).

Version of Record published: September 6, 2023 (This version)
Accepted Manuscript published: August 23, 2023 (Go to version)
Accepted: July 12, 2023
Received: June 7, 2023
Preprint posted: April 28, 2022 (Go to version)

1. Of interest
Deep learning insights into the architecture of the mammalian egg-sperm fusion synapse

Arne Elofsson, Ling Han ... Luca Jovine

Research Article Apr 26, 2024
Further reading

Abstract
Editor's evaluation
Introduction
Results
Discussion
Materials and methods
Appendix 1
Data availability
References
Article and author information
Metrics

Abstract

Pancreatic islets are three-dimensional cell aggregates consisting of unique cellular composition, cell-to-cell contacts, and interactions with blood vessels. Cell aggregation is essential for islet endocrine function; however, it remains unclear how developing islets establish aggregation. By combining genetic animal models, imaging tools, and gene expression profiling, we demonstrate that islet aggregation is regulated by extracellular matrix signaling and cell-cell adhesion. Islet endocrine cell-specific inactivation of extracellular matrix receptor integrin β1 disrupted blood vessel interactions but promoted cell-cell adhesion and the formation of larger islets. In contrast, ablation of cell-cell adhesion molecule α-catenin promoted blood vessel interactions yet compromised islet clustering. Simultaneous removal of integrin β1 and α-catenin disrupts islet aggregation and the endocrine cell maturation process, demonstrating that establishment of islet aggregates is essential for functional maturation. Our study provides new insights into understanding the fundamental self-organizing mechanism for islet aggregation, architecture, and functional maturation.

Editor's evaluation

This important study advances our knowledge regarding how islet endocrine cells interact with one another and with surrounding blood vessels during embryonic development and in adult mice. The evidence supporting this work is convincing, with complementary microscopy, functional and transcriptomic data. The authors' conclusions are supported by the data with sample size and quantitative analyses. These data should be of broad interest to islet biologists.

https://doi.org/10.7554/eLife.90006.sa0

Introduction

To control various physiological responses, groups of endocrine cells cluster together with vasculature, mesenchymal cells, and neuronal cells to form a highly organized ‘mini-organ’ in the pancreatic epithelium: the islet of Langerhans. The islet endocrine cells emerge from a domain of multipotent progenitors in the embryonic pancreatic epithelium. Initially, the multipotent pancreatic progenitors resolve into a pre-acinar domain, and a bipotent endocrine/ductal progenitor domain of the developing pancreas (Larsen and Grapin-Botton, 2017; Romer and Sussel, 2015; Shih et al., 2013). Endocrine cell progenitors are specified by the expression of the proendocrine gene Neurogenin 3 (Ngn3) (Gu et al., 2002). Following endocrine cell specification, the Ngn3⁺ precursors undergo delamination (Bechard et al., 2016; Gouzi et al., 2011; Rosenberg et al., 2010). Delaminated endocrine precursors remain associated with the ducts as they migrate and join other endocrine cells and aggregate into immature islets (Sharon et al., 2019a). These immature islets form long interconnected cords along the ductal epithelium. Later the islet cords change morphology and undergo fission to form distinct spherical islets (Jo et al., 2011; Seymour et al., 2004; Sznurkowska et al., 2020). Throughout the differentiation and morphological changes, endocrine cells are intimately associated with the vasculature, which facilitates functional control of hormone release (Reinert et al., 2014). To coordinate the hormone release of endocrine cells within each islet, autocrine and paracrine interactions, as well as direct cell contacts, are required (Campbell and Newgard, 2021). These interactions are established by the aggregation process during development (Adams and Blum, 2022). Defects in the aggregation processes may lead to defects in endocrine cell development, and eventually, islet dysfunction. Supporting this notion, human pluripotent stem cell (hPSC)-derived β-cells acquire more functional maturity in vitro if clustered together (Cottle et al., 2021; Nair et al., 2019). However, the mechanism by which this process is regulated in vivo has largely remained elusive.

Self-organization of a group of cells into a higher-order, multicellular functional unit relies on an array of cell interactions regulated by cell-cell adhesions (Fagotto, 2014). For example, a calcium-dependent adhesion molecule, neural cell adhesion molecule (N-CAM), has been shown to be critical for murine endocrine cells to cluster (Esni et al., 1999). In rodents, islets form a stereotypical core-mantle architecture in which the insulin (Ins) secreting β-cells are located mainly in the central core, with glucagon (Gcg) secreting α-cells and somatostatin (Sst) secreting δ-cells localizing in the periphery to form a mantle (Adams and Blum, 2022; Arrojo e Drigo et al., 2015; Kim et al., 2009). In culture, dissociated rat endocrine cells can self-organize into the core-mantle architecture, suggesting that the islet structure is established by factors intrinsic to endocrine cells (Halban et al., 1987). N-CAM-deleted mice show abnormal islet architecture, with α-cells spread throughout the islet core and abnormal assembly of adherens junction proteins N- and E-cadherin (Ncad and Ecad) (Esni et al., 1999). In addition, ectopic expression of a dominant negative Ecad in mouse β-cells interferes with their clustering and islet formation (Dahl et al., 1996); and loss of Ecad results in abnormal blood glucose homeostasis (Wakae-Takada et al., 2013). Intracellularly, adherens junctions are stabilized by β-catenin (Ctnnb1) and α-catenin (Ctnna1) (Jamora and Fuchs, 2002). The function of Ctnnb1 has been extensively studied in the developing pancreas (Elghazi et al., 2012; Murtaugh et al., 2005; Rulifson et al., 2007) and in hPSC-derived β-cells, because of its role in cell proliferation via Wnt signaling (Sharon et al., 2019b); yet genetic studies show that Ctnnb1 is not essential for islet clustering and architecture (Elghazi et al., 2012; Murtaugh et al., 2005). In the developing pancreas, inactivation of Ctnna1 results in defects in endocrine progenitor differentiation due to an expansion of pancreatic ductal progenitors (Jimenez-Caliani et al., 2017). Whether the process of islet clustering and architecture requires Ctnna1 is unknown.

The regulation of cell-cell adhesion is often coupled with cell-extracellular matrix (ECM) interaction and integrin signaling (Mui et al., 2016; Weber et al., 2011). Upon ECM binding, integrins activate signal transduction pathways and regulate (1) cytoskeleton dynamics, (2) cell movement, (3) cell differentiation, and (4) functional maturation of epithelial cells, vasculature, and neurons (Barros et al., 2011; Li et al., 2008; Scheppke et al., 2012). During angiogenesis, ECM receptor integrin β1 (Itgb1) is required to control the localization of cell-cell adhesion molecule VE-cadherin and maintain cell-cell junction integrity (Yamamoto et al., 2015). In salivary glands and early embryonic pancreas, Itgb1-mediated ECM adhesions regulate Ecad to control cell clustering and regulate budding epithelial branching (Shih et al., 2016; Wang et al., 2021; Wang et al., 2017). Whether islet morphogenesis also requires ECM-integrin signaling remains to be investigated.

In the present study, we examine how loss of Itgb1 and Ctnna1 in Ngn3-expressing endocrine progenitors affects islet morphogenesis. We show that Itgb1 and Ctnna1 have collaborative roles during islet aggregation: ECM-Itgb1 signaling modulates islet aggregation by negatively regulating cell-cell adhesions; and α-catenin promotes endocrine cell clustering and modulates vascularization during islet development. We also provide evidence that the islet architecture is regulated by differential adhesion in endocrine subtypes.

Results

The morphogenesis and functional maturation of islet endocrine cells depend on ECM-Itgb1 signaling during development

To investigate the process of islet aggregation, embryonic day 15.5 (E15.5) pancreas was stained for blood vessel maker platelet endothelial cell adhesion molecule-1 (PECAM), ductal marker Spp1, and endocrine cell marker chromogranin A (ChrA). Confocal microscopy and three-dimensional (3D) whole-mount immunofluorescence (IF) imaging revealed that at E15.5 endocrine cells had started aggregating, and the vascular and ductal networks were already highly similar (Figure 1—figure supplement 1A). This close relation between the ducts and blood vessels at the stage prior to islet aggregation suggests that blood vessels could readily interact and provide instructive cues to regulate endocrine progenitor aggregation into islets. Blood vessels in islets produce ECM-rich basal membrane to support and organize endocrine cells (Lammert et al., 2003; Roscioni et al., 2016). Thus, we hypothesized that ECM signaling, provided by the vasculature, plays a key role in the initiation steps of islet aggregation. Supporting this notion, published work using single-cell gene expression profiling has shown that the ECM-Itgb1 signaling gene ontology (GO) categories are most significantly enriched in the Ngn3⁺ endocrine progenitors (Bastidas-Ponce et al., 2019). IF analysis validated that both the Ngn3⁺ endocrine progenitors and their progenies (eYFP⁺ cells in Ngn3-Cre; Rosa26-eYFP pancreas) expressed Itgb1 (Figure 1A). To investigate the role of Itgb1 during endocrine cell aggregation, we used the Ngn3-Cre allele to recombine the Itgb1-flox alleles in endocrine progenitors (Ngn3-Cre; Itgb1^f/f; hereafter Itgb1^{ΔEndo/ΔEndo}). Expression of Itgb1 was almost entirely absent throughout the islet endocrine cells in comparison to control littermates at 6 weeks of age (Figure 1B and C). We first examined whether inactivation of ECM-Itgb1 signaling affected vascular interaction. Electron microscope ultrastructure analysis revealed tight attachment in basal membranes between vascular and endocrine cells in control islets (Figure 1—figure supplement 1B). In contrast, in the Itgb1^{ΔEndo/ΔEndo} islets, the endocrine cells were detached from the basal membranes of blood vessels (Figure 1—figure supplement 1C, red arrows). Despite the vascular defects with Itgb1 loss, all four endocrine cell subtypes, α-, β-, δ-, and Ppy- (pancreatic polypeptide) cells, were present at similar proportions in control and Itgb1^{ΔEndo/ΔEndo} islets (Figure 1D and E; Figure 1—figure supplement 1D–G). In addition, the expression of β-cell lineage markers Nkx6.1 and Pdx1 were present in the Ins⁺ cells of control and Itgb1^{ΔEndo/ΔEndo} islets (Figure 1F and G). Although the populations of endocrine cell lineages were unaffected by the loss of Itgb1, morphometrical analysis revealed drastic morphological changes. In control islets, β-cells were organized in a central core and surrounded by α- and δ-cells in the periphery (Figure 1D). Conversely, in Itgb1^{ΔEndo/ΔEndo} mice, several individual islets appeared to agglomerate, resulting in larger islet sizes and aberrant distribution of α- and δ-cells in the central core (Figure 1E and G; Figure 1—figure supplement 1I). Thus, the inactivation of Itgb1 has a profound impact on islet morphogenesis, but not endocrine cell fate choice.

Figure 1 with 2 supplements see all

Download asset Open asset

ECM-Itgb1 signaling in endocrine progenitors is required for normal islet morphology and function.

(A) Immunofluorescence staining for Itgb1 and Ngn3 in pancreas sections of *Ngn3-Cre; Rosa26eYFP* reporter mice at E15.5. Cyan arrows indicate Ngn3⁺ cells and lineage-traced endocrine cells expressing Itgb1. (**B–C**) Immunofluorescence staining for Itgb1, Ins, and DAPI on pancreas sections, demonstrating significant *Itgb1* deletion in an *Itgb1^{ΔEndo/ΔEndo}* islet at 6 weeks of age. Fields demarcated by white boxes in (**B–C**) are shown with individual color channels in (**B’–C’**) side panels. (**D–G**) Immunofluorescence staining for Gcg, Ins, Sst, Nkx6.1, Pdx1, and DAPI on pancreas sections of (**D, F**) control and (**E, G**) *Itgb1^{ΔEndo/ΔEndo}* mice at 6 weeks of age. Individual islets are outlined by dotted lines. Fields demarcated by yellow boxes in (**D–G**) are shown at higher magnification in (**D’–G’**) side panels. (H) Gene-set enrichment analysis of the differentially expressed genes, indicating top enriched pathways for control versus *Itgb1^{ΔEndo/ΔEndo}* islets at 6 weeks of age. Gene sample sizes and FDRs are indicated by the size and color of the dots. (I) Heatmap demonstrating down-regulation (Group 1) and up-regulation (Group 2) of functional maturation genes in *Itgb1^{ΔEndo/ΔEndo}* islets compared to controls. (**J–L**) Intraperitoneal glucose tolerance test (**J, L**) and stimulated insulin secretion at T15 (K) on 6- to 16-week-old (**J, K**) and (L) 6- to 12-month-old control and *Itgb1^{ΔEndo/ΔEndo}* mice. Ngn3, neurogenin 3; Gcg, glucagon; Ins, insulin; DAPI, 4’,6-diamidino-2-phenylindole; Sst, somatostatin; IPGTT, intraperitoneal glucose tolerance test; FDR, false discovery rate; E15.5, embryonic day 15.5. Data are shown as mean ± SEM. *p<0.05 and **p<0.01.

Figure 1—source data 1 Related to Figure 1J.: https://cdn.elifesciences.org/articles/90006/elife-90006-fig1-data1-v2.xlsx
Download elife-90006-fig1-data1-v2.xlsx
Figure 1—source data 2 Related to Figure 1K.: https://cdn.elifesciences.org/articles/90006/elife-90006-fig1-data2-v2.xlsx
Download elife-90006-fig1-data2-v2.xlsx
Figure 1—source data 3 Related to Figure 1L.: https://cdn.elifesciences.org/articles/90006/elife-90006-fig1-data3-v2.xlsx
Download elife-90006-fig1-data3-v2.xlsx

We next investigated whether the loss of Itgb1 had any impact on the expression of genes related to islet function. Islets from 6-week-old control and Itgb1^{ΔEndo/ΔEndo} mice were isolated and subjected to RNA-sequencing (RNA-seq) and differential gene expression analysis. A comparison of gene expression profiles between Itgb1^{ΔEndo/ΔEndo} and control islets revealed 417 differentially expressed genes (DEGs) with false discovery rate (FDR)<0.05 and fold change (FC) >2 (Supplementary file 1), of which 332 were up-regulated and 85 were down-regulated. Gene-set enrichment analysis (GSEA) of DEGs between control and Itgb1^{ΔEndo/ΔEndo} islets showed up-regulation of pathways associated with hypoxia, epithelial mesenchymal transition, glycolysis, and inflammatory response (Figure 1H). The analysis of GO of DEGs related to hypoxia showed that the genes responsible for hypoxia response were up-regulated in Itgb1^{ΔEndo/ΔEndo} islets when compared to the control group (as shown in Figure 1—figure supplement 1L). The IF analysis indicated that the Itgb1^{ΔEndo/ΔEndo} islets at 2–3 months of age displayed a significant reduction in blood vessels (as shown in Figure 1—figure supplement 1M–O), which suggests that the lack of vascular interaction could lead to hypoxia responses. On the other hand, the down-regulated genes were associated with spermatogenesis, pancreas β-cells, and E2F targets (Figure 1H). GO analysis of DEGs in the pancreas β-cells category further revealed that functional maturation genes for β-cells (e.g., Slc2a2 [Glut2], Ucn3, and Mafa) and for α-cells (e.g., Arx, Mafb, and Etv1), were drastically down-regulated in the Itgb1^{ΔEndo/ΔEndo} islets (Figure 1I, Group 1; Figure 1—figure supplement 2A). IF analysis also validated the reduced expression of Mafa, Ucn3, and Glut2 in β-cells of Itgb1^{ΔEndo/Δendo} islets (Figure 1—figure supplement 2B–E). Furthermore, several ‘disallowed’ genes for β-cells, including Ldha1, Aldh1a3, and Hk1 (Lemaire et al., 2016), were significantly up-regulated in the Itgb1^{ΔEndo/ΔEndo} islets (Figure 1I, Group 2; Figure 1—figure supplement 2A). Hence, it is likely that the functional maturation of endocrine cells within Itgb1^{ΔEndo/ΔEndo} islets is compromised. This notion is supported by the observation that, by 6 weeks of age, these mice exhibit glucose intolerance and reduced insulin secretion in response to glucose stimulation (Figure 1J–K). The impairment in glycemic regulation further deteriorates in mice older than 6 months (Figure 1L). Together, these observations indicate that ECM-integrin interactions are critical for islet vascularization, morphogenesis, and the functional maturation of endocrine cells.

ECM signaling regulates endocrine progenitor cell migration and cell-cell adhesion to control islet aggregation during development

Our initial analysis of the pancreatic sections from Itgb1^{ΔEndo/ΔEndo} mice revealed larger islet sizes (Figure 1—figure supplement 1J). Consistently, the islets isolated from Itgb1^{ΔEndo/ΔEndo} mice appeared larger in size as well (Figure 2A–C); however, the total islet area was similar between control and Itgb1^{ΔEndo/ΔEndo} mice (Figure 2D). The increased size was mainly attributed to a greater number of large islets (>50 µm² × 10³, as shown in Figure 1—figure supplements 1K and 2E). Therefore, the enlarged islet size is likely a result of a morphological change independent of the expansion of total endocrine cells. Furthermore, in the control pancreata, the islets were located near the ducts, but contained a very small number of ductal cells (Figure 2F and H; Figure 2—figure supplement 1A). In contrast, the islets in the Itgb1^{ΔEndo/ΔEndo} pancreata contained a substantial number of ductal cells (Figure 2G and H; Figure 2—figure supplement 1B). As the endocrine progenitors arise and migrate away from the ducts, we hypothesized that there might be deficiencies in this process for Itgb1-deficient endocrine cells. To investigate this, we conducted segmentation analysis of 3D whole-mount IF on E15.5 pancreata, the stage at which the majority of endocrine progenitor migration occurs (Rosenberg et al., 2010). Our results showed that most of the Itgb1-deleted endocrine progenitor cell aggregates had a greater tendency to cluster within the ductal cords during development (Figure 2I and J and Video 1; the green color represents zero distance from ducts). These findings imply that there might be deficiencies in both endocrine cell migration and premature islet aggregation in Itgb1-deleted endocrine cells. To further confirm this, we conducted live imaging analysis on pancreas explants obtained from E16.5 Ngn3-Cre; Rosa26mT/mG; Itgb1^+/+ (control) and Ngn3-Cre; Rosa26mT/mG; Itgb1^f/f (Itgb1^{ΔEndo/ΔEndo}) mice. We tracked the movement and aggregation of Ngn3-progeny (mGFP⁺) endocrine progenitor cells in explant cultures for up to 3 days (Figure 2—figure supplement 1C and D; Videos 2 and 3). Our observations showed that in contrast to the controls, where endocrine progenitor cells migrated and aggregated outside of ductal cords, the mGFP⁺ cells in Itgb1^{ΔEndo/ΔEndo} explants readily aggregated before moving away from the cords (Figure 2—figure supplement 1D, white arrows). In contrast to our findings, previous studies using Ins-Cre or RIP-Cre to ablate Itgb1 after endocrine progenitors have differentiated into insulin-producing cells did not report any observable islet aggregation or migration defects (Diaferia et al., 2013; Win et al., 2020). However, Ngn3-Cre-mediated Itgb1 deletion would occur much earlier in embryonic stages (Figure 1A), suggesting that Itgb1 signaling regulates the migration and aggregation of progenitor cells in the endocrine lineage during the islet developmental process.

Figure 2 with 2 supplements see all

Download asset Open asset

Itgb1 signaling is required for proper endocrine progenitor aggregation.

(**A–B**) Brightfield images of isolated islets from control and *Itgb1^{ΔEndo/ΔEndo}* mice at 8 weeks of age. (**C–E**) Quantification of (C) average islet size, (D) total islet area, and (E) islet size distribution based on morphometric analysis of 8-week-old control and *Itgb1^{ΔEndo/ΔEndo}* isolated islets. (**F–G**) Immunofluorescence staining for Spp1, Ins, and DAPI on 6-week-old control and *Itgb1^{ΔEndo/ΔEndo}* pancreas sections. Islets are outlined by white dotted lines. (H) The ratio of ductal cell areas within the islets is quantified based on Spp1 and ChrA staining of pancreas sections from 6-week-old control and *Itgb1^{ΔEndo/ΔEndo}* mice. (**I–J**) Three-dimensional (3D) segmentation analysis on whole-mount immunofluorescence images of E15.5 control and *Itgb1^{ΔEndo/ΔEndo}* pancreata stained for ChrA and Spp1 (white colored) reveals that the endocrine cells in the *Itgb1^{ΔEndo/ΔEndo}* pancreas are mostly retained within ducts, and the distance between endocrine cells and ducts is represented by a color scale. (**K–L**) Airyscan super-resolution images depict immunofluorescence staining for Ecad and ductal marker DBA in P7 mT/mG reporter mice showing up-regulation of Ecad in the *Itgb1^{ΔEndo/ΔEndo}* pancreas. The dot-like Ecad expression pattern in super-resolution imaging represents adherens junction structures. The yellow boxes in (**K–L**) demarcate fields shown at higher magnification in (**K’–L’**) side panels. (M) The schematic depicts the experimental design for the in vitro aggregation assay. (N) Aggregate size is quantified after a 2 hr incubation with or without extracellular matrix (ECM). (**O–R**) Fluorescence images of mGFP⁺ endocrine progenitor aggregates after 2 hr of culture show that mGFP⁺ control endocrine progenitors clustered (O) without ECM but remained single cells (P) with ECM. Alternatively, *Itgb1^{ΔEndo/ΔEndo}* endocrine progenitors clustered (Q) without ECM or (R) with ECM. Spp1, secreted phosphoprotein 1; Ins, insulin; DAPI, 4’,6-diamidino-2-phenylindole; Ecad, E-cadherin; DBA, *Dolichos biflorus* agglutinin; P7, postnatal day 7; E15.5, embryonic day 15.5. Data are shown as mean ± SEM. *p<0.05, **p<0.01, and ****p<0.0001.

Figure 2—source data 1 Related to Figure 2C.: https://cdn.elifesciences.org/articles/90006/elife-90006-fig2-data1-v2.xlsx
Download elife-90006-fig2-data1-v2.xlsx
Figure 2—source data 2 Related to Figure 2D.: https://cdn.elifesciences.org/articles/90006/elife-90006-fig2-data2-v2.xlsx
Download elife-90006-fig2-data2-v2.xlsx
Figure 2—source data 3 Related to Figure 2E.: https://cdn.elifesciences.org/articles/90006/elife-90006-fig2-data3-v2.xlsx
Download elife-90006-fig2-data3-v2.xlsx
Figure 2—source data 4 Related to Figure 2H.: https://cdn.elifesciences.org/articles/90006/elife-90006-fig2-data4-v2.xlsx
Download elife-90006-fig2-data4-v2.xlsx
Figure 2—source data 5 Related to Figure 2N.: https://cdn.elifesciences.org/articles/90006/elife-90006-fig2-data5-v2.xlsx
Download elife-90006-fig2-data5-v2.xlsx

Video 1

Download asset

posterframe for video — Three-dimensional (3D) segmentation analysis on whole-mount immunofluorescence images of embryonic day 15.5 (E15.5) control and *Itgb1^{ΔEndo/ΔEndo}* pancreata.

This file presents a 3D segmentation analysis based on the chromogranin A (ChrA) and secreted phosphoprotein 1 (Spp1) staining, revealing islet clusters and pancreatic ducts. It includes movie clips showcasing the 3D segmentation from various viewing angles. A color scale illustrates the distance between endocrine cells and ducts, with cooler colors indicating shorter distances.

Video 2

Download asset

Video 3

Download asset

To further investigate this notion, we sought to inactivate Itgb1 only after the endocrine cells had fully differentiated and matured. Urocortin 3 (Ucn3) is a late β-cell-specific maturity marker in mouse islets that is expressed after Ins1 and Ins2 and starts perinatally. Most β-cells express Ucn3 by 3 weeks of age (Blum et al., 2014; van der Meulen and Huising, 2014). The expression pattern of Cre recombinase under the control of the Ucn3 promoter aligns with this timeline (van der Meulen et al., 2017). Therefore, Ucn3-Cre-mediated deletion of Itgb1 is not expected to occur until islet development has completed in the presence of functional Itgb1 alleles and normal Itgb1 expression. To test whether Itgb1 signaling also maintains islet cell aggregation after β-cell maturation and islet formation, we crossed Ucn3-Cre with Itgb1^f/f mice to inactivate Itgb1 exclusively in mature β-cells (referred to as Itgb1^{ΔMatureβ/ΔMatureβ}). Our analysis revealed that, similar to Itgb1^{ΔEndo/ΔEndo} mice, Itgb1^{ΔMatureβ/ΔMatureβ} mice exhibited vasculature exclusion from islets (Figure 2—figure supplement 1E’ and F’), but islet size remained similar to control mice (Figure 2—figure supplement 1E–1I). These results suggest that Itgb1 signaling specifically regulates islet cell aggregation during pancreatic development.

During the early stages of pancreas development, the expression of Itgb1 in pancreatic progenitor cells has been identified as a crucial factor in controlling pancreas branching morphogenesis through its regulation of cell-cell adhesion (Shih et al., 2016). As the process of endocrine progenitor cell differentiation and islet formation commences, cell-cell adhesion is typically down-regulated to facilitate the migration and interaction of endocrine cells with non-endocrine cells (Gouzi et al., 2011). Given the established role of Itgb1 in regulating cell-cell adhesion in the context of pancreas development, we were prompted to investigate whether Itgb1 signaling also plays a role in instructing endocrine progenitor cells to modulate their adhesion behavior and thereby control the islet aggregation process. To address this question, we took Airyscan super-resolution images of Ecad IF on endocrine cells in Ngn3-Cre; Rosa26mT/mG; Itgb1^f/f islets at P7, since islet aggregation is complete by the neonatal stages (Sznurkowska et al., 2020). The Airyscan images provide sufficient resolution to show adherens junctions between cells by visualizing Ecad⁺ clusters (Gonschior et al., 2020; white dots in Figure 2K and L). The lineage-traced endocrine cells (mGFP⁺) in control islets displayed low amounts of Ecad⁺ clusters (Figure 2K’). However, the amount of Ecad⁺ clusters was drastically increased in mutant islets (Figure 2L’), suggesting that Itgb1 signaling negatively regulates cell adhesion in developing islets. To further test whether the increased cell adhesiveness is responsible for the increased islet size when Itgb1 signaling is disrupted, we performed an in vitro cell aggregation assay. Live mGFP⁺ endocrine cells, from neonatal (P2-P4) Ngn3-Cre; Rosa26mT/mG; Itgb1^+/f or Ngn3-Cre; Rosa26mT/mG; Itgb1^f/f pancreata, were completely dissociated, then collected by fluorescence-activated cell sorting (FACS). 3000 mGFP⁺ cells were allowed to aggregate in wells of a 96-well plate that were coated with bovine serum albumin (BSA) (no ECM) or Matrigel and fibronectin (+ECM) (Figure 2M). Within 2 hr of cell seeding, the control mGFP⁺ endocrine cells rapidly aggregated in wells with no ECM coating, but formed no aggregates in the ECM-coated wells (Figure 2N–P). Within the same amount of time, the mutant mGFP⁺ endocrine cells clustered into larger aggregates in wells without ECM coating and maintained aggregation in the ECM-coated wells (Figure 2N, Q and R). After 48 hr, the mGFP⁺ cells isolated from both the controls and mutants progressively clustered into larger aggregates in wells without ECM coating (Figure 2—figure supplement 2A, C, E). In contrast, in the ECM-coated wells, only the mutant mGFP⁺ cells clustered, while control mGFP⁺ cells remained unaggregated (Figure 2—figure supplement 2D and F). Together, these findings demonstrate that ECM-Itgb1 signaling negatively regulates islet aggregation. As integrins play a crucial role in linking the actin cytoskeleton, we examined whether the inactivation of Itgb1 in endocrine progenitors affects the organization of the actin cytoskeleton in islet cells. In Itgb1^{ΔEndo/ΔEndo} islets, we observed pronounced foci of condensed F-actin between the endocrine cells (Figure 2—figure supplement 2G–J), indicating increased cell-cell adhesion. These findings suggest that the loss of Itgb1 in endocrine cells leads to alterations in the actin cytoskeleton, resulting in enhanced cell-cell adhesion within the islet microenvironment. The concentrated F-actin foci between the endocrine cells indicate a potential mechanism through which Itgb1 regulates cell-cell interactions and influences islet development and aggregation.

α-Catenin promotes endocrine cell aggregation and regulates vascularization during islet development

Our study revealed that Itgb1 plays a critical role in islet development by regulating endocrine cell-cell adhesion. However, the mechanism by which cell-cell adhesion regulates islet formation remains unclear. Although Ecad and Ncad-mediated adherens junctions are believed to be the primary cell-cell adhesion mechanisms linking islet cells into aggregates, our findings and other studies have shown that deletions of Ecad or Ncad alone do not affect islet aggregation, suggesting functional redundancy between these cell adhesion molecules.

α-Catenin (Ctnna1) is an essential hub protein linking Ecad-mediated adherens junctions to the cytoskeleton and has been demonstrated to be indispensable for the formation of adherens junctions (Jamora and Fuchs, 2002). Therefore, to investigate the requirement of cell adhesion in islet formation, we conditionally ablated Ctnna1 in endocrine progenitors by generating Ngn3-Cre; Ctnna1^f/f mice (hereafter referred to as Ctnna1^{ΔEndo/ΔEndo}). To determine whether Ctnna1 deletion affects islet development, ChrA staining on pancreas sections from 8-week-old mice were imaged, and the total relative islet area was measured (Figure 3A and B). Compared to their wild-type littermates, islet area (relative to the total pancreas area) in Ctnna1^{ΔEndo/ΔEndo} mice was unchanged (Figure 3C), but there was a significant reduction in average islet size (Figure 3D). The proportion of larger islets was significantly reduced, while the proportion of small islets was increased (Figure 3—figure supplement 1A–C), suggesting that Ctnna1 is required for proper islet aggregation, but not for the development of total islet cell mass. In Ctnna1^{ΔEndo/ΔEndo} islets, we observe diminished Ecad expression and a decrease in the density of F-actin at cell junctions. These findings imply a disruption of cell junctions and a reduction in cell adhesion among Ctnna1-deficient endocrine cells (Figure 3E and F).

Figure 3 with 1 supplement see all

Download asset Open asset

Ctnna1-mediated cell-cell adhesion is required for normal islet morphology and endocrine cell aggregation.

(**A–B**) Immunofluorescence staining for ChrA and DAPI in 8-week-old pancreas sections showing smaller islet sizes in *Ctnna1^{ΔEndo/ΔEndo}* mice. (**C–D**) Quantification of (C) the percentage of islet area in pancreas area and (D) average islet size based on ChrA staining on 8-week-old control and *Ctnna1^{ΔEndo/ΔEndo}* pancreas sections. (**E–F**) Airyscan images of immunofluorescence staining for Ecad, ChrA, F-actin, and DAPI for control and *Ctnna1^{ΔEndo/ΔEndo}* pancreas sections. Fields demarcated by yellow boxes are shown at higher magnification with individual color channels in (**E’–F’**) middle panels, showing reduced expression of Ecad and F-actin in *Ctnna1^{ΔEndo/ΔEndo}* islets. Individual endocrine cell shape is delineated by yellow lines in (**E”–F”**), demonstrating the enlarged endocrine cell sizes in the islets of *Ctnna1^{ΔEndo/ΔEndo}* mice. (G) Heatmap showing genes for extracellular matrix (ECM) signaling and blood vessel interactions are up-regulated in *Ctnna1^{ΔEndo/ΔEndo}* islets at 8 weeks of age. Groups 1–7 represent gene ontologies of: (1) metalloproteases, (2) vascular adhesion, (3) collagens, (4) integrins, (5) laminins, (6) glycoproteins, and (7) thrombospondins. (**H–I**) Immunofluorescence staining of Ins and PECAM on 8-week-old control and *Ctnna1^{ΔEndo/ΔEndo}* pancreas sections. (J) Quantification of islet blood vessel density based on Ins and PECAM staining on 8-week-old control and *Ctnna1^{ΔEndo/ΔEndo}* pancreas sections. (**K–L**) Immunofluorescence staining of Ins and PECAM on P14 control and *Ctnna1^{ΔEndo/ΔEndo}* pancreas sections showing increased vasculature in *Ctnna1^{ΔEndo/ΔEndo}* islets. Islet area is outlined by dotted lines. ChrA, chromogranin A; DAPI, 4’,6-diamidino-2-phenylindole; Ecad, E-cadherin; Ins, insulin; PECAM, platelet endothelial cell adhesion molecule-1; P14, postnatal day 14. Data are shown as mean ± SEM. ****p<0.0001.

Figure 3—source data 1 Related to Figure 3C.: https://cdn.elifesciences.org/articles/90006/elife-90006-fig3-data1-v2.xlsx
Download elife-90006-fig3-data1-v2.xlsx
Figure 3—source data 2 Related to Figure 3D.: https://cdn.elifesciences.org/articles/90006/elife-90006-fig3-data2-v2.xlsx
Download elife-90006-fig3-data2-v2.xlsx
Figure 3—source data 3 Related to Figure 3J.: https://cdn.elifesciences.org/articles/90006/elife-90006-fig3-data3-v2.xlsx
Download elife-90006-fig3-data3-v2.xlsx

To investigate how Ctnna1 deletion impacts islet development, we compared transcriptional profiling of Ctnna1^{ΔEndo/ΔEndo} and control islets at 8 weeks. A comparison of gene expression profiles between Ctnna1^{ΔEndo/ΔEndo} and control islets revealed significant differences in the expression of 319 genes with FDR <0.05 and FC >2, of which 245 were up-regulated and 74 were down-regulated (Supplementary file 2). Among all GO categories, one of the most up-regulated groups in Ctnna1^{ΔEndo/ΔEndo} islets is genes associated with ECM signaling and blood vessel interactions (Figure 3G; Figure 3—figure supplement 1D). These include metalloproteases, vascular adhesion, collagens, integrins, laminins, glycoproteins, and thrombospondins (Figure 3G). These findings suggest that Ctnna1^{ΔEndo/ΔEndo} islets have augmented ECM signaling and blood vessel interaction. IF for blood vessels confirmed an increase in blood vessel density in Ctnna1^{ΔEndo/ΔEndo} islets at 8 weeks (Figure 3H–J). The increase in islet vasculature was observed as early as P14 (Figure 3K–L). These findings demonstrated that the inactivation of Ctnna1 in endocrine progenitor cells led to a decrease of endocrine cell-cell adhesion and an increase in blood vessel interaction.

Alongside the increased interaction with blood vessels, we observed abnormal organization of F-actin fibers within Ctnna1^{ΔEndo/ΔEndo} islets (Figure 3E and F; Figure 3—figure supplement 1E and F). These alterations in F-actin fiber organization were evident as early as P14 in the Ctnna1^{ΔEndo/ΔEndo} islets, concurrent with the onset of enhanced interaction with blood vessels (Figure 3—figure supplement 1G and H). These findings demonstrate that the loss of Ctnna1 compromises endocrine cell aggregation and perturbs the organization of the actin cytoskeleton and cell-cell adhesion. Together, these findings suggest that the balance between cell-cell adhesion and blood vessel interaction is crucial for islet cell aggregation during development (Figure 3—figure supplement 1I).

Inactivation of Ctnna1 in differentiating endocrine cells affects the assembly and maintenance of non-β-endocrine cells in islets

To further investigate the impact of Ctnna1-dependent islet cell aggregation on the islet development process, we compared the gene expression profiles of Ctnna1^{ΔEndo/ΔEndo} and control islets. Our analysis revealed significant misregulation of genes crucial for endocrine cell functions. Specifically, we observed a down-regulation of Slc27a2, Tmsb15b1, and Etv1 expression, which are genes required for glycemic control and insulin secretion (Figure 4A Group 1; Figure 4—figure supplement 1A,). Conversely, we found an up-regulation of Hk1, Ldha, Aldh1a1, and Cxcl14 expression, which are genes known to be ‘disallowed’ in mature functional β-cells (Lemaire et al., 2016; Figure 4A Group 2; Figure 4—figure supplement 1A). These findings suggest that the function of β-cells may be negatively impacted in Ctnna1^{ΔEndo/ΔEndo} mice.

Figure 4 with 1 supplement see all

Download asset Open asset

Ctnna1 is required for proper islet functionality and α-cell survival.

(A) Heatmap showing the top up-regulated (Group 1) and down-regulated (Group 2) endocrine cell lineage and functional genes in *Ctnna1^{ΔEndo/ΔEndo}* islets from 8-week-old mice. (**B–D**) The figure shows the results of the intraperitoneal glucose tolerance test (**B, D**) and stimulated insulin secretion assay (C) performed on control and *Ctnna1^{ΔEndo/ΔEndo}* mice at 8 weeks of age (**B, C**) and 12 months of age (D). The *Ctnna1^{ΔEndo/ΔEndo}* mice exhibited glucose intolerance, but no detectable difference in insulin secretion compared to control littermates. The *Ctnna1^{ΔEndo/ΔEndo}* mice are glucose intolerant with non-detectable insulin secretion defects. (**E–F**) Immunofluorescence staining for Gcg, Ins, and DAPI on 8-week-old (E) control and (F) *Ctnna1^{ΔEndo/ΔEndo}* pancreas sections showing a reduction of α-cells. (**G–H**) Quantification of (G) Ins⁺ and (H) Gcg⁺ area relative to total pancreas area in 8-week-old control and *Ctnna1^{ΔEndo/ΔEndo}* pancreas sections. (**I–K**) Quantification of endocrine cell area (I), Gcg⁺ (J), and Sst⁺ (K) relative to total pancreas area in control and *Ctnna1^{ΔEndo/ΔEndo}* pancreas sections at P0 and P7. Note that there was no significant difference observed between the control and *Ctnna1^{ΔEndo/ΔEndo}* pancreas sections at P0 and P7. (**L–N**) Immunofluorescence staining for Gcg, TUNEL, and DAPI on P7 control and *Ctnna1^{ΔEndo/ΔEndo}* pancreas sections. White arrows indicate TUNEL⁺/Gcg⁺ cells. The percentage of TUNEL⁺/Gcg⁺ co-positive cells relative to total Gcg⁺ cell numbers in P7 control and *Ctnna1^{ΔEndo/ΔEndo}* islets is shown in panel (N), and compared to controls, the *Ctnna1^{ΔEndo/ΔEndo}* islets exhibited significantly more TUNEL⁺/Gcg⁺ cells at P7. Gcg, glucagon; Ins, insulin; DAPI, 4’,6-diamidino-2-phenylindole; IPGTT, intraperitoneal glucose tolerance test; TUNEL, terminal deoxynucleotidyl transferase dUTP nick end labeling; P0, postnatal day 0; P7, postnatal day 7. Data are shown as mean ± SEM. *p<0.05, **p<0.01, ***p<0.001, ****p<0.0001.

Figure 4—source data 1 Related to Figure 4B.: https://cdn.elifesciences.org/articles/90006/elife-90006-fig4-data1-v2.xlsx
Download elife-90006-fig4-data1-v2.xlsx
Figure 4—source data 2 Related to Figure 4C.: https://cdn.elifesciences.org/articles/90006/elife-90006-fig4-data2-v2.xlsx
Download elife-90006-fig4-data2-v2.xlsx
Figure 4—source data 3 Related to Figure 4D.: https://cdn.elifesciences.org/articles/90006/elife-90006-fig4-data3-v2.xlsx
Download elife-90006-fig4-data3-v2.xlsx
Figure 4—source data 4 Related to Figure 4G.: https://cdn.elifesciences.org/articles/90006/elife-90006-fig4-data4-v2.xlsx
Download elife-90006-fig4-data4-v2.xlsx
Figure 4—source data 5 Related to Figure 4H.: https://cdn.elifesciences.org/articles/90006/elife-90006-fig4-data5-v2.xlsx
Download elife-90006-fig4-data5-v2.xlsx
Figure 4—source data 6 Related to Figure 4I.: https://cdn.elifesciences.org/articles/90006/elife-90006-fig4-data6-v2.xlsx
Download elife-90006-fig4-data6-v2.xlsx
Figure 4—source data 7 Related to Figure 4J.: https://cdn.elifesciences.org/articles/90006/elife-90006-fig4-data7-v2.xlsx
Download elife-90006-fig4-data7-v2.xlsx
Figure 4—source data 8 Related to Figure 4K.: https://cdn.elifesciences.org/articles/90006/elife-90006-fig4-data8-v2.xlsx
Download elife-90006-fig4-data8-v2.xlsx
Figure 4—source data 9 Related to Figure 4N.: https://cdn.elifesciences.org/articles/90006/elife-90006-fig4-data9-v2.xlsx
Download elife-90006-fig4-data9-v2.xlsx

To support this notion, we conducted glucose tolerance tests, which revealed mild glucose intolerance in Ctnna1^{ΔEndo/ΔEndo} mice at 8 weeks (Figure 4B). However, the quantification of insulin content in serum after glucose challenge did not reveal any noticeable insulin secretion defect in the Ctnna1^{ΔEndo/ΔEndo} mice (Figure 4C). We reasoned that the conventional serum insulin measurement may not reflect the changes in β-cell function, given that the Ctnna1^{ΔEndo/ΔEndo} mice exhibit only mild glucose intolerance. Therefore, we performed quantification of insulin secretion in vivo using hyperglycemic clamps, which is a more sensitive detection method. In this assay, we observed a trend toward lower overall insulin secretion in the Ctnna1^{ΔEndo/ΔEndo} mice at 8 weeks (Figure 4—figure supplement 1B and C), providing additional evidence that Ctnna1-dependent islet cell aggregation has an impact on β-cell function. In addition, the glucose intolerance phenotype became even more pronounced at 1 year of age, as evidenced by the glucose tolerance test (Figure 4D). These findings indicate that Ctnna1-dependent islet cell aggregation is crucial for the proper development of β-cells and their function in maintaining glucose homeostasis.

In addition to suggested functional defects in β-cells, we found that genes for non-β-endocrine cell lineages, including α-cell genes Gcg, MafB, Arx, Peg10, and Etv1, and the δ-cell gene Sst, were significantly down-regulated in Ctnna1^{ΔEndo/ΔEndo} islets (Figure 4A; Figure 4—figure supplement 1A), suggesting the requirement of Ctnna1 for the presence of non-β-endocrine cells in islets. Interestingly, Ctnna1^{ΔEndo/ΔEndo} islets did not show a reduced area of β-cells, as β-cells were still loosely organized in the core of islets (Figure 4E–G). However, there was a severe reduction of α-cell and δ-cell populations in the Ctnna1-deleted islets (Figure 4H; Figure 4—figure supplement 1D–F). To determine whether the loss of non-β-endocrine cells was the result of differentiation defects during development, we examined the population of α- and β-cells in Ctnna1^{ΔEndo/ΔEndo} islets at P0 and P7. At these ages, the islets of Ctnna1^{ΔEndo/ΔEndo} mice exhibited normal endocrine cell mass, Gcg⁺ α-cell and Sst⁺ δ-cell areas (Figure 4I–K; Figure 4—figure supplement 1G–J), demonstrating that the loss of α- and δ-cell was not due to differentiation defects prior to these early stages. However, the detachment of α-cells from the mantle of Ctnna1^{ΔEndo/ΔEndo} islets was observed by P7. By this timepoint, α-cells had formed tight interactions with other endocrine cells in control islets (Figure 4—figure supplement 1I and K), but Ctnna1-deficient α-cells detached from other cell types (Figure 4—figure supplement 1J and L). To investigate whether cell detachment promotes cell death, thus resulting in α-cell loss, TUNEL analysis on P7 Ctnna1^{ΔEndo/ΔEndo} islets was conducted to analyze cell apoptosis. Compared to the control, Ctnna1^{ΔEndo/ΔEndo} islets display three times more TUNEL⁺ apoptotic α-cells (Figure 4L–N), indicating that Ctnna1 is required for α-cell survival. Thus, the loss of the α-cells in Ctnna1^{ΔEndo/ΔEndo} islets during adulthood is not due to endocrine cell differentiation defects; instead, a drastic increase in apoptosis explains the loss of α-cells in the Ctnna1-deleted islets.

Differential adhesion in endocrine cells controls the formation of islet architecture

Since the reduction of cell-cell adhesion caused distinctive outcomes in different endocrine cell subtypes, we hypothesized that the endocrine cells in the mantle or core of islets may have different adhesiveness. We re-analyzed publicly available gene expression profiles (DiGruccio et al., 2016) to examine the expression of key cell adhesion molecules E-cadherin, N-cadherin, α-catenin, and β-catenin between the subtypes of endocrine cells. These adhesion genes were expressed at the highest level in β-cells, while their expression was comparatively lower in endocrine cells located in the mantle of islets (α-cells and δ-cells, Figure 5—figure supplement 1A). These observations suggest that the adhesive properties may differ between endocrine cell subtypes. According to the differential adhesion hypothesis (DAH), a population of cells with different adhesive properties will tend to spontaneously sort themselves to maximize adhesive bonding (Foty and Steinberg, 2005). Stronger adhesion between β-cells may lead them to bundle into islet cores, while the weaker adhesion between non-β-cells results in their dispersion into islet mantles.

Based on the DAH, if the cell adhesion is altered in different endocrine subpopulations, the stereotypical islet architecture will also be affected. To alter the cell adhesion in different endocrine subpopulations, we crossed Ins1-Cre and Gcg-iCre lines to Ctnna1-flox mice and traced the Ctnna1-deleted β- or α-cells with the lineage tracer Rosa26-mT/mG (Ins1-Cre; Ctnna1^f/f; Rosa26-mT/mG and Gcg-iCre; Ctnna1^f/f; Rosa26-mT/mG, hereafter Ctnna1^Δβ/Δβ and Ctnna1^Δα/Δα mice, respectively). The Rosa26-mT/mG lineage-tracing allele faithfully reported the Ins1-Cre and Gcg-iCre cell lineages at P7 (Figure 5A–H), allowing examination of the respectively labeled β- and α-cells using mGFP expression. The mGFP⁺ β-cells of Ctnna1^Δβ/+ mice are mostly located on the islet core (Figure 5A and E), and the mGFP⁺ α-cells of Ctnna1^Δα/+ mice are mostly located in the islet mantle (Figure 5C and G). Additionally, we found that β-cells exhibited strong F-actin condensed cellular junctions with well-organized rosette structures (Figure 5—figure supplement 1B, yellow arrows). In contrast, α-cells displayed loosely bundled F-actin assemblies without focal-condensed junctional structures found in control mice (Figure 5—figure supplement 1D, yellow arrows), supporting the notion that α-cells may have relatively low adhesive properties. Inactivation of Ctnna1 in β-cells and α-cells significantly diminished the formation of F-actin, as indicated in Figure 5—figure supplement 1C and E (highlighted by yellow arrows). This suggests a substantial decrease in cell adhesion assemblies within the β-cells of Ctnna1^Δβ/Δβ and the α-cells of Ctnna1^Δα/α islets.

Figure 5 with 1 supplement see all

Download asset Open asset

Loss of Ctnna1 in α- and β-cells leads to disrupted islet architecture.

(**A–H**) Airyscan images of immunofluorescence staining for Ins (**A–D**), Gcg (**E–H**), and DAPI in pancreas sections of P7 mT/mG reporter mice: Heterozygous *Ctnna1^Δβ/+* (**A, E**), homozygous *Ctnna1^Δβ/Δβ* (**B, F**), heterozygous *Ctnna1^Δα/+* (**C, G**), and homozygous *Ctnna1^Δα/Δα* (**D, H**). The yellow arrows in (F) showing α-cells in the islet core in *Ctnna1^Δβ/Δβ* mice. The fields demarcated by yellow boxes are shown at higher magnification with individual color channels in the side panels. (**I–J**) Quantification of α-cell localization in the islets of *Ctnna1^Δβ/Δβ* (I) and *Ctnna1^Δα/Δα* (J) mice. Compared to controls, *Ctnna1^Δβ/Δβ* and *Ctnna1^Δα/Δα* mice exhibit a reduction in peripherally located α-cells and an increase in core-located α-cells. These results suggest that the loss of Ctnna1 in α- and β-cells affects the organization and localization of α-cells within the islet. Gcg, glucagon; DAPI, 4’,6-diamidino-2-phenylindole; Ins, insulin; P7, postnatal day 7. Data are shown as mean ± SEM. ***p<0.001, ****p<0.0001.

Figure 5—source data 1 Related to Figure 5I.: https://cdn.elifesciences.org/articles/90006/elife-90006-fig5-data1-v2.xlsx
Download elife-90006-fig5-data1-v2.xlsx
Figure 5—source data 2 Related to Figure 5J.: https://cdn.elifesciences.org/articles/90006/elife-90006-fig5-data2-v2.xlsx
Download elife-90006-fig5-data2-v2.xlsx

Based on the DAH proposed by previous studies, we expected that Ctnna1-expressing α-cells would tend to cluster together and become more concentrated toward the center of Ctnna1^Δβ/Δβ islets due to weaker adhesion in β-cells lacking Ctnna1. Our observations supported this hypothesis: in Ctnna1^Δβ/Δβ islets, where only β-cell adhesion was affected but not α-cell adhesion, we observed a significant decrease in α-cells at the periphery and an increase in their density at the core of the islets (Figure 5B, F and I). Additionally, our data revealed that islet core-located α-cells had a higher tendency to form clusters (Figure 5F). These results are consistent with the prediction of DAH that cells with stronger adhesion tend to exclude those with weaker adhesion and to form a cluster with a defined size.

However, in α-cell-specific Ctnna1 deletion (Ctnna1^Δα/Δα) mutants, we observed a reduction in α-cells at the periphery and an increase in their frequency in the islet core (Figure 5D, H and J), which was unexpected based on the predictions of DAH. Nevertheless, the core-located Ctnna1-deficient α-cells were mostly scattered as single cells without clustering together in the islet of Ctnna1^Δα/Δα mice (Figure 5H). This suggests that the role of Ctnna1 in regulating cellular distribution within the islets may be more complex than the simple attractor-repeller mechanism proposed by DAH. These observations support the idea that differential adhesion between endocrine subtypes is a contributing factor for establishing the islet architecture during development; and the weaker cell adhesion in the peripheral islet layers leads to the specific loss of these cell types in Ctnna1^{ΔEndo/ΔEndo} islets.

Coordination of ECM and cell-cell adhesion regulates islet vascularization, architecture, and functional maturation

Our studies have shown that the coordination of cell-ECM and cell-cell adhesion plays a vital role in regulating islet development. These adhesions work together to balance interactions between endocrine cells and blood vessels. When one of these adhesions is perturbed, islet endocrine cells may compensate with another interaction to maintain islet aggregation (Figure 3—figure supplement 1). However, it is still unclear whether islet clustering relies solely on these two adhesions. To test this, we generated Ngn3-Cre; Ctnna1^f/f; Itgb1^f/f (hereafter Ctnna1; Itgb1^{ΔEndo/ΔEndo}) double knockout (DKO) mice, in which we simultaneously removed cell-ECM and cell-cell adhesion in all endocrine progenitor cells. We compared control, Ctnna1^{ΔEndo/ΔEndo}, Itgb1^{ΔEndo/ΔEndo} and DKO islets at P7 to examine their morphology.

At P7, Ctnna1^{ΔEndo/ΔEndo} islets displayed loosely aggregated endocrine cells, increased vascularization (Figure 6A and B), reduced F-actin assemblies, and more active-Itgb1⁺ endothelial cells in the loosened islet aggregates (Figure 6—figure supplement 1A and B). Conversely, Itgb1^{ΔEndo/ΔEndo} islets clumped together (Figure 6C), with strong F-actin assemblies and less active-Itgb1⁺ endothelial cells in the tightly aggregated islets (Figure 6—figure supplement 1C). However, the aggregation of endocrine cells was completely abrogated in the DKO mice (Figure 6D). These DKO endocrine cells became suspended single cells scattered throughout the entire pancreatic epithelium, displaying rounded cell morphology (Figure 6D). The DKO endocrine cells were larger and displayed weak F-actin assemblies (Figure 6—figure supplement 1D). Despite the drastic changes in endocrine cell aggregation and morphology, the endocrine cell subtypes were still present in the P7 DKO islets (Figure 6D and data not shown), suggesting that the differentiation of endocrine subtypes is independent of the islet aggregation process.

Figure 6 with 1 supplement see all

Download asset Open asset

Disruption of cell-extracellular matrix (ECM) and/or cell-cell adhesion results in abnormal islet vascular architecture, endocrine cell aggregation, and decreased expression of β-cell maturation markers at postnatal day 7.

(**A–D**) Immunofluorescence staining of PECAM, Ins, Gcg, and DAPI in P7 (A) control, (B) *Ctnna1^{ΔEndo/ΔEndo}*, (C) *Itgb1^{ΔEndo/ΔEndo}*, and (D) *Ctnna1; Itgb1^{ΔEndo/ΔEndo}* mice. Fields demarcated by yellow boxes in (A–D) are shown at higher magnification in (A’–D’) side panels. Individual islet shape is outlined by dashed yellow lines in (A’–C’). Endocrine cells are suspended and scattered throughout the pancreas of *Ctnna1; Itgb1^{ΔEndo/ΔEndo}* mice. (**E–L**) Airyscan images of immunofluorescence staining for Ucn3, Glut2, Ins, and DAPI in P7 (**E, I**) control, (**F, J**) *Ctnna1^{ΔEndo/ΔEndo}*, (**G, K**) *Itgb1^{ΔEndo/ΔEndo}*, and (**H, L**) *Ctnna1; Itgb1^{ΔEndo/ΔEndo}* mice. Arrows indicate reduced expression of Ucn3 or Glut2 in β-cells of the mutant mice. PECAM, platelet endothelial cell adhesion molecule-1; Ins, insulin; Gcg, glucagon; DAPI, 4’,6-diamidino-2-phenylindole; Ucn3, urocortin 3; Glut2, Slc2a2; P7, postnatal day 7.

We next investigated whether the failure in islet aggregation affected endocrine cell maturation by performing IF for β-cell maturation markers. In P7 control mice, Ucn3 and Glut2 were robustly expressed in the cytosol and cell surface of β-cells, respectively (Figure 6E and I). Deletion of Ctnna1 or Itgb1 in endocrine progenitor cells led to reduced expression of Ucn3 and Glut2 in β-cells (Figure 6F, G, J, and K), which was consistent with gene profiling analysis from 8-week-old mice. Finally, DKO islets displayed a severe loss of β-cell maturation markers in P7 β-cells (Figure 6H and L). In addition, while endocrine cells in normal islets do not express progenitor markers Sox9 or Spp1 at P7 (Figure 6—figure supplement 1E and G), the endocrine cells in the DKO islets exhibited elevated expression of these markers at P7 (Figure 6—figure supplement 1F and H). These findings suggest that β-cell maturation is linked to the cell adhesion-mediated islet aggregation process.

To investigate whether the islet aggregation and β-cell maturation defects in DKO mice at P7 were due to developmental delays, we examined islets during later adulthood stages. At 8 weeks, normal endocrine cells form tightly aggregated islets (Figure 7A), but in DKO mice, endocrine cells remain mostly scattered, forming smaller and loosely attached clusters (Figure 7B). These smaller clusters of endocrine cells abnormally express progenitor markers Sox9 and Spp1 (Figure 7B; and data not shown). While the endocrine cells appear to be located closely to each other in lower resolution images, Airyscan super-resolution images of F-actin IF on endocrine cells in DKO islets showed that the endocrine cells are completely separated from each other without forming discernible junction structures (Figure 7C and D, yellow arrows). Furthermore, the endocrine cells also exhibit separation from the vasculatures in the DKO islets (Figure 7C and D, red arrows). These observations indicate that both the islet aggregation and the β-cell maturation defects in DKO mice persist into adulthood. Supporting this, low expression of β-cell maturation markers Ucn3 and Glut2 persisted in 8-week-old DKO islets (Figure 7F–H). These mice were severely glucose intolerant (Figure 7I) and exhibit very low insulin secretion upon glucose stimulation (Figure 7J). Together, our findings support a model in which islet morphogenesis, vasculature interaction, endocrine cell aggregation, and the β-cell maturation process depend on cell-ECM and cell-cell adhesion during development (Figure 7K).

Figure 7

Download asset Open asset

Abnormal islet aggregation, mis-regulation of β-cell maturation markers, and insulin secretion defects persist in *Ctnna1; Itgb1^{ΔEndo/ΔEndo}* mice into adulthood.

(**A–B**) Immunofluorescence staining for endocrine cell marker ChrA and progenitor marker Spp1 on pancreas sections from control (A) and *Ctnna1; Itgb1^{ΔEndo/ΔEndo}* (B) mice at 8 weeks of age. The yellow boxes in (A, B) indicate the fields shown at higher magnification in (A’, B’) side panels. In the islets of *Ctnna1; Itgb1^{ΔEndo/ΔEndo}* mice, a subpopulation of ChrA⁺ endocrine cells expresses progenitor markers Spp1 (yellow cells in **B and B’**). (**C–D**) Airyscan images of immunofluorescence staining for Ins, F-actin, and DAPI in pancreatic sections from 8-week-old control and *Ctnna1; Itgb1^{ΔEndo/ΔEndo}* mice are shown. In control islets (**C, C'**), the F-actin assemblies appear aligned with cell membranes and condensed in cellular junctions, as indicated by the yellow and red arrows, respectively. In contrast, diffused distribution of F-actin (red arrows in D’) and separation of F-actin assemblies (yellow arrows in D’) between Ins⁺ β-cells are observed in the *Ctnna1; Itgb1^{ΔEndo/ΔEndo}* mice. (**E–F**) Immunofluorescence staining of Ucn3, Ins, and DAPI in pancreatic sections of 8-week-old (E) control and (F) *Ctnna1; Itgb1^{ΔEndo/ΔEndo}* mice. Fields demarcated by white boxes in (E and F) are shown at higher magnification in (**E’ and F’**), and individual islet shape is outlined by dashed white lines. The reduction of Ucn3 expression persists in adult *Ctnna1; Itgb1^{ΔEndo/ΔEndo}* mice. (**G–H**) Immunofluorescence staining of Glut2, Ins, and DAPI in 8-week-old (G) control and (H) *Ctnna1; Itgb1^{ΔEndo/ΔEndo}* mouse pancreas. Fields demarcated by white boxes in (G and H) are shown at higher magnification in (G’ and H’), and individual islet shape is outlined by dashed white lines. The reduction of Glut2 expression persists in adult *Ctnna1; Itgb1^{ΔEndo/ΔEndo}* mice. (**I–J**) Intraperitoneal glucose tolerance test was performed on 8-week-old mice (I), and glucose-stimulated insulin secretion was measured at T15 in 20- to 38-week-old mice (J) from control and *Ctnna1; Itgb1^{ΔEndo/ΔEndo}* groups. *Ctnna1; Itgb1^{ΔEndo/ΔEndo}* mice exhibited severe glucose intolerance and defects in insulin secretion. (K) Graphical summary of the islet phenotypes observed after disruption of cell-cell and cell-extracellular matrix (ECM) adhesion. Ins, insulin; ChrA, chromogranin A; Spp1, secreted phosphoprotein 1; Ucn3, urocortin 3; IPGTT, intraperitoneal glucose tolerance test. Data are shown as mean ± SEM. *p<0.05 and **p<0.01.

Figure 7—source data 1 Related to Figure 7I.: https://cdn.elifesciences.org/articles/90006/elife-90006-fig7-data1-v2.xlsx
Download elife-90006-fig7-data1-v2.xlsx
Figure 7—source data 2 Related to Figure 7J.: https://cdn.elifesciences.org/articles/90006/elife-90006-fig7-data2-v2.xlsx
Download elife-90006-fig7-data2-v2.xlsx

Discussion

Our study reveals the combinatorial roles of cell-ECM and cell-cell adhesion in regulating the aggregation of endocrine cells into islets. Mechanistically, islet cell aggregation depends on endocrine cell-cell adhesion, which is negatively regulated by cell-ECM adhesion through vascular interaction. These two adhesion properties are reciprocally regulated: lowering cell-ECM adhesion promotes endocrine cell-cell adhesion; and, conversely, lowering cell-cell adhesion promotes cell-ECM adhesion. Importantly, the aggregation and functional maturation processes of endocrine cells are affected by the loss of either adhesion property and are further affected by the loss of both.

In this study, we aimed to elucidate the role of ECM signaling by specifically deleting the essential ECM receptor Itgb1 during endocrine specification. Our findings demonstrate that while the morphology and function of Itgb1^{ΔEndo/ΔEndo} islets were impacted, the total islet area remained unaffected, suggesting that Itgb1 deletion may not result in overt cell death in islets, unlike in other organ systems (Carlson et al., 2008; Speicher et al., 2014). These observations indicate the involvement of other mediators of cell-ECM interactions in islet maintenance. Although Itgb1 is a key player in cell-ECM interactions, compensatory mechanisms involving other integrins, such as β3, β4, β5, β6; and α3, α6, αV integrins, may be operative in Itgb1-deficient islets. Previous studies have highlighted the critical roles of these integrins in cell-ECM interactions and islet biology (Cirulli et al., 2000; Krishnamurthy et al., 2011; Schiesser et al., 2021; Yashpal et al., 2005). It is plausible that these integrins compensate for cell-ECM interactions, ensuring the survival and function of Itgb1-deficient islets. Further investigations are warranted to comprehensively understand the compensatory mechanisms and contributions of other integrins in Itgb1-deficient islets.

Both Itgb1^{ΔEndo/ΔEndo} and Itgb1^{ΔMatureβ/ΔMatureβ} mice demonstrate reduced vascularization, highlighting the importance of ECM signaling in vascular interactions throughout stages from embryonic endocrine cells to mature β-cells. This aligns with previous research using MIP-Cre to create Itgb1-knockout mice, which also exhibited decreased islet vascularization (Win et al., 2020). The critical role of Itgb1 signaling in organ vascularization seems universal; studies indicate that Itgb1 inactivation in pituitary endocrine epithelial cells and kidney cells leads to a loss of vasculature (Mohamed et al., 2020; Scully et al., 2016). Reduced vascular interaction can instigate hypoxia responses, which have been tied to β-cell maturation processes (Balboa et al., 2022; Heinis et al., 2010; Zeng et al., 2017). We thus propose that the impaired β-cell maturation observed in Itgb1^{ΔEndo/ΔEndo} mice could stem from a hypoxic state caused by vascular loss. However, this hypothesis requires further empirical investigation for validation.

The expression of Vegfa, an essential growth factor for islet vasculature, is not affected in Itgb1^{ΔEndo/ΔEndo} islets (Supplementary file 1). Thus, the reduced vascularization in Itgb1-deficient islets may not be explained by the lack of Vegfa. Downstream of integrin signaling, integrin-linked kinase (ILK) is activated upon integrin-ECM binding to regulate actin organization, cell migration, and other cellular processes (Hannigan et al., 2005). Genetic deletion of ILK in the developing pancreas leads to the failure of ILK-inactivated endocrine cells to adhere to the basement membrane, and a drastic reduction of intra-islet blood vessel density (Kragl et al., 2016). This study further showed that cortical actomyosin contraction was significantly increased, thus increasing cortex tension in both the ILK-deleted islets and in Itgb1-inactivated cultured β-cells. Our analyses showed aberrant organization of F-actin fibers and compaction of individual endocrine cells, as well as dysregulated cytoskeleton genes in Itgb1-deleted islets. Thus, it is likely that both the Itgb1^{ΔEndo/ΔEndo} and Itgb1^{ΔMatureβ/ΔMatureβ} islets fail to interact with vasculature resulting in the same alteration of the actomyosin regulation seen in ILK-deleted islet cells. In contrast, the Ctnna1^{ΔEndo/ΔEndo} model shows increased islet vascularization without affecting the expression of Vegfa (Supplementary file 2). We posit that weakened adhesion between endocrine cells in Ctnna1^{ΔEndo/ΔEndo} islets may allow greater penetration of vasculature through islet clusters, leading to augmented islet vascularization. Supporting this notion, salivary gland patterning allows vessel penetration via an epithelial ‘cleft’ created by weakened cell-cell adhesion (Kwon et al., 2017). Interestingly, the initial steps of cleft formation requires ECM-Itgb1 signaling (Sakai et al., 2003); conversely, reducing cell-cell adhesion promotes cell-ECM adhesion during budding morphogenesis (Wang et al., 2021). Thus, our proposed model, in which ECM signaling in concert with cell-cell adhesion controls islet aggregation, may reflect a fundamental mechanism of organ morphogenesis.

In the context of our findings, it is crucial to consider the potential role of vascular alignment in islet cell function. The vasculature system within the islet plays an indispensable role not only in delivering nutrients to the cells but also in facilitating the efficient distribution of hormones into the peripheral circulation (Gan et al., 2018). The functional maturation of β-cells and their efficiency in hormone secretion are likely influenced by their proximity to and interaction with the vasculature. In our Itgb1- and Ctnna1-deficient models, we observed an abnormal aggregation of islet cells, resulting in scattered cells that appear misaligned with the vasculature. This disorganization could potentially impair nutrient delivery and hormone distribution, further exacerbating the functional impairments seen in these models. It is plausible that, in addition to their impact on cell-cell adhesion and aggregation, the inactivation of Itgb1 and Ctnna1 may also interfere with the proper integration of β-cells with the islet vasculature. This perspective adds another layer to our understanding of the complex interplay between cellular adhesion, aggregation, and the vasculature in islet morphology and function.

The onset of the proendocrine cell program triggers the expression of Ngn3, a factor thought to stimulate the activation of ECM signaling. This signaling pathway is regarded as a key regulatory mechanism controlling the delamination and migration of proendocrine cells away from ductal progenitor cords (Rosenberg et al., 2010). In the case of Itgb1^{ΔEndo/ΔEndo} mice, the deactivation of ECM signaling in these endocrine progenitors leads to a noticeable decrease in their migration distances. Consequently, differentiated endocrine cells remain entangled with ducts post-differentiation from as early as E15.5, highlighting the role of ECM signaling in facilitating endocrine progenitor migration during initial developmental stages. Interestingly, this phenomenon of reduced migration is not observed in Itgb1^{ΔMatureβ/ΔMatureβ} islets, suggesting the impact of ECM signaling on cell migration may be more specific to the progenitor stage. Supporting this hypothesis, studies utilizing Ins-Cre or RIP-Cre to ablate Itgb1 in post-differentiated insulin-producing cells have reported no discernible migration defects (Diaferia et al., 2013; Win et al., 2020). During the limited time window of endocrine cell development, islet cell radial migration is also modulated by semaphorin signaling (Pauerstein et al., 2017). The remodeling of actin, induced by semaphorin, is associated with changes in the cell anchorage to the ECM (Alto and Terman, 2017). This suggests that the chemoattractant system, where semaphorin signaling occurs, could potentially intersect with the activation of Itgb1 signaling. This intersection of signaling pathways may guide the migration of islet progenitor cells toward the periphery and away from the ducts. Thus, the chemoattractant system where semaphorin signaling occurs may involve the activation of Itgb1 signaling to control islet progenitor cell migration toward the periphery, and away from the ducts. Whether the migration of endocrine progenitors toward the periphery affects their function remains to be tested. However, the role of ECM-integrin signaling extends beyond the scope of cell migration. In adult stages, ECM-integrin signaling continues to have a significant impact on differentiated endocrine cells within pancreatic islets (Gan et al., 2018). Therefore, when we use the term ‘endocrine cells’ in this study, we refer to both progenitor and differentiated cells, and the significance of ECM-integrin signaling spans across multiple cellular processes, not being confined to migration alone.

Despite the endocrine subtype ratios being different in human versus rodent islets, the precise differences in the stereotypical architectures in the two species have been debated. Studies using different imaging modalities have yielded different conclusions (Dybala et al., 2020). In mice, it is proposed that spatiotemporal collinearity leads to the typical core-mantle architecture of the spherical islet in which α-cells, the first to develop, form the peninsular outer layer, and β-cells subsequently form beneath them (Sharon et al., 2019a). Our current study has not directly tested this hypothesis, yet our observations suggest that differential cell adhesion is critical for developing this structure. Our data support a model in which randomly allocated α- and β-cells are specified and sorted into the final islet architecture based on differential adhesion. It remains to be tested whether the differential cell adhesion is also involved in the development of islet architectures in human. In addition, studies have shown that the Roundabout (Robo)/Slit signaling axis plays a role in determining islet stereotypical architecture. The secreted ligand, Slit, is often associated with the ECM, and binds to Robo receptors to control various cellular responses via cytoplasmic kinases and the regulation of actin and microtubule cytoskeleton (Jiang et al., 2022; Tong et al., 2019). Mice lacking Robo1 and Robo2 in all endocrine cells, or selectively in β-cells, show complete loss of endocrine cell type sorting in the islets (Adams et al., 2021; Adams et al., 2018; Gilbert et al., 2020). Interestingly, Robo1/2 DKO islets exhibit adhesion defects and are prone to dissociate upon isolation (Adams et al., 2018), similar to the Ctnna1^{ΔEndo/ΔEndo} islets. Similar observations have been shown in stem cell sorting and cancer cell migration; binding of Slit to Robo receptors leads to the modulation of Ncad- or Ecad-mediated cell adhesion (Stine et al., 2014; Tong et al., 2019). We speculate that Robo/Slit signaling regulates endocrine cell type sorting in islets by controlling cell adhesive properties to establish the islet architecture.

Limitation of the study

Our study’s potential limitation is the use of the Ngn3-Cre driver for targeted gene deletion. While commonly used for pancreatic endocrine progenitor and its lineage-specific gene deletion, Ngn3 is also expressed in other tissues such as the brain and gastrointestinal tract (Schonhoff et al., 2004; Simon-Areces et al., 2010). Deletion of genes using this driver could impact these other tissues and create unintended consequences. Previous studies show that Ctnna1 deletion in neuronal progenitor cells in the brain can lead to altered neural cell proliferation and differentiation (Lien et al., 2006). Although we did not investigate the potential effects of Itgb1 and Ctnna1 deletion in these other tissues, further studies are necessary to comprehend the role of ECM signaling and cell adhesion in these other tissues and the potential consequences of their deletion using the Ngn3-Cre driver.

We acknowledge the intricate interplay between cell-ECM and cell-cell interactions and understand that the loss of one type of interaction does not universally enhance the other. This complexity was exemplified in our DKO model, which did not exhibit the expected compensatory behaviors. While our in vitro cell adhesion assay provided some insight, we recognize its limitations in fully mirroring the dynamic and sophisticated changes occurring in vivo. Consequently, our observations serve as preliminary findings that pave the way for more comprehensive investigation. Further research, particularly in more complex, dynamic models, will be vital in elucidating the precise nature of these interactions and their role in cell development and function. The dynamic nature of islet aggregation and endocrine subtype sorting would require more in-depth live imaging analysis. Obtaining 3D cellular information in developing islets would provide insights into these dynamic and complex phenomena, and further our understanding of the process of islet development and morphogenesis. We anticipate that using pancreas slice cultures (Panzer et al., 2020) to develop an imaging platform to monitor the development of live neonatal islets would provide a framework for understanding how islets develop, and offer novel ways to harness this understanding in the search for clinical alternatives to treat diabetes.

Reagent type (species) or resource	Designation	Source or reference	Identifiers	Additional information
Antibody	Goat polyclonal anti- Pancreatic Polypeptide/PP	Novus Biologicals	Cat# NB100-1793 RRID: AB_2268669	IHC (1:1000)
Antibody	Mouse monoclonal anti-Glucagon	Sigma-Aldrich	Cat# G2654 RRID: AB_259852	IHC (1:500)
Antibody	Goat anti-Glucagon Antibody (N-17)	Santa Cruz Biotechnology	Cat# sc-7780 RRID: AB_641025	IHC (1:500)
Antibody	Guinea Pig polyclonal anti-Insulin	Dakocytomation	Cat# A0564 RRID: AB_10013624	IHC (1:2000)
Antibody	Rabbit monoclonal anti-Insulin	Cell Signaling Technology	Cat# 3014 S RRID: AB_2126503	IHC & WMIHC (1:1000)
Antibody	Rabbit polyclonal anti-Chromogranin A	Novus Biologicals	Cat# NB120-15160 RRID: AB_789299	IHC & WMIHC (1:500)
Antibody	Goat polyclonal anti-Chromogranin A	Santa Cruz Biotechnology	Cat# sc-1488 RRID: AB_2276319	IHC & WMIHC (1:500)
Antibody	Goat polyclonal anti-Somatostatin	Santa Cruz Biotechnology	Cat# sc-7819 RRID: AB_2302603	IHC (1:100)
Antibody	Rat monoclonal anti-Mouse CD31	BD Biosciences	Cat# 550274 RRID: AB_393571	IHC & WMIHC (1:200)
Antibody	Goat polyclonal anti-PECAM-1	R&D Systems	Cat# AF3628 RRID: AB_2161028	IHC (1:500)
Antibody	Goat polyclonal anti- Osteopontin/OPN (Spp1)	R&D Systems	Cat# AF808 RRID: AB_2194992	IHC & WMIHC (1:1000)
Antibody	Guinea Pig polyclonal anti-Neurogenin3	A generous gift of Maike Sander (Henseleit et al., 2005)		IHC (1:1000)
Antibody	Mouse monoclonal anti-Nkx6.1	DSHB	Cat# F55A10 RRID: AB_532378	IHC (1:500)
Antibody	Rabbit polyclonal anti-Pdx1	Abcam	Cat# ab47267 RRID: AB_777179	IHC (1:500)
Antibody	Rabbit polyclonal anti-Laminin (Lam1)	Sigma-Aldrich	Cat# L9393 RRID: AB_477163	IHC (1:1000)
Antibody	Rat monoclonal anti-EPCAM	DSHB	Cat# G8.8 RRID: AB_2098655	IHC (1:100)
Antibody	Goat polyclonal anti-E-cadherin	R&D Systems	Cat# AF748 RRID: AB_355568	IHC (1:500)
Antibody	Rabbit polyclonal anti-MafA	Abcam	Cat# ab26405 RRID: AB_776146	IHC (1:200)
Antibody	Rabbit polyclonal anti-Urocortin3 (Ucn3)	A generous gift of Mark Huising (van der Meulen et al., 2015)		IHC (1:1000)
Antibody	Goat polyclonal anti-Glut2	Santa Cruz Biotechnology	Cat# sc-7580 RRID: AB_641066	IHC (1:500)
Antibody	Rat monoclonal anti-CD29 (Itgβ1)	BD Biosciences	Cat# 550531 RRID: AB_393729	IHC (1:500)
Antibody	Rabbit monoclonal anti-Ki67	Cell Signaling	Cat# 12202 S (D3B5) RRID: AB_2620142	IHC (1:500)
Antibody	Rabbit anti-Sox9 antibody	EMD Millipore	Cat# AB5535 RRID: AB_2239761	IHC (1:500)
Antibody	Rabbit polyclonal anti-ERO1b antiserum	A generous gift of David Ron (Zito et al., 2010)		IHC (1:300)
Antibody	Cy3 AffiniPure Donkey Anti-Goat IgG (H+L) (donkey polyclonal)	Jackson ImmunoResearch	Cat# 705-165-147 RRID: AB_2307351	IHC (1:2000)
Antibody	Alexa Fluor 488 AffiniPure Donkey Anti-Goat IgG (H+L) (donkey polyclonal)	Jackson ImmunoResearch	Cat# 705-545-147 RRID: AB_2336933	IHC (1:1000)
Antibody	Alexa Fluor 647 AffiniPure Donkey Anti-Goat IgG (H+L) (donkey polyclonal)	Jackson ImmunoResearch	Cat# 705-605-147 RRID: AB_2340437	IHC (1:200–500)
Antibody	Cy3 AffiniPure Donkey Anti-Guinea Pig IgG (H+L) (donkey polyclonal)	Jackson ImmunoResearch	Cat# 706-165-148 RRID: AB_2340460	IHC (1:2000)
Antibody	Alexa Fluor 488 AffiniPure Donkey Anti- Guinea Pig IgG (H+L) (donkey polyclonal)	Jackson ImmunoResearch	Cat# 706-545-148 RRID: AB_2340472	IHC (1:1000)
Antibody	Alexa Fluor 647 AffiniPure Donkey Anti-Guinea Pig IgG (H+L) (donkey polyclonal)	Jackson ImmunoResearch	Cat# 706-605-148 RRID: AB_2340476	IHC (1:200–500)
Antibody	Cy3 AffiniPure Donkey Anti-Rabbit IgG (H+L) (donkey polyclonal)	Jackson ImmunoResearch	Cat# 711-165-152 RRID: AB_2307443	IHC (1:2000)
Antibody	Alexa Fluor 488 AffiniPure Donkey Anti-Rabbit IgG (H+L) (donkey polyclonal)	Jackson ImmunoResearch	Cat# 711-545-152 RRID: AB_2313584	IHC (1:1000)
Antibody	Alexa Fluor 647 AffiniPure Donkey Anti-Rabbit IgG (H+L) (donkey polyclonal)	Jackson ImmunoResearch	Cat# 711-605-152 RRID: AB_2492288	IHC (1:200–500)
Antibody	Cy3 AffiniPure Donkey Anti-Rat IgG (H+L) (donkey polyclonal)	Jackson ImmunoResearch	Cat# 712-165-153 RRID: AB_2340667	IHC (1:2000)
Antibody	Alexa Fluor 488 AffiniPure Donkey Anti-Rat IgG (H+L) (donkey polyclonal)	Jackson ImmunoResearch	Cat# 712-545-153 RRID: AB_2340684	IHC (1:1000)
Antibody	Alexa Fluor 647 AffiniPure Donkey Anti-Rat IgG (H+L) (donkey polyclonal)	Jackson ImmunoResearch	Cat# 712-605-153 RRID: AB_2340694	IHC (1:200–500)
Commercial assay, kit	Dolichos Biflorus Agglutinin (DBA), Biotinylated	Vector Laboratories	Cat# B1035 RRID: AB_2314288	IHC (1:500)
Commercial assay, kit	Dolichos Biflorus Agglutinin (DBA), Rhodamine	Vector Laboratories	Cat# RL-1032–2 RRID: AB_2336396	IHC (1:500)
Commercial assay, kit	DAPI (4',6-Diamidino-2-Phenylindole, Dihydrochloride)	ThermoFisher Scientific	Cat# D1306	IHC (1:2000)
Commercial assay, kit	Phalloidin-iFluor 647 Reagent	Abcam	Cat# ab176759	IHC (1:1000)

Share this article

Cite this article

ECM-Itgb1 signaling in endocrine progenitors is required for normal islet morphology and function.

Figure 1—source data 1

Figure 1—source data 2

Figure 1—source data 3

Itgb1 signaling is required for proper endocrine progenitor aggregation.

Figure 2—source data 1

Figure 2—source data 2

Figure 2—source data 3

Figure 2—source data 4

Figure 2—source data 5

Three-dimensional (3D) segmentation analysis on whole-mount immunofluorescence images of embryonic day 15.5 (E15.5) control and Itgb1ΔEndo/ΔEndo pancreata.

Time-lapse confocal microscope imaging of endocrine progenitor cell behaviors in embryonic day 15.5 (E16.5) control (Ngn3Cre; Rosa26mT/mG) embryonic pancreas explants.

Time-lapse confocal microscope imaging of endocrine progenitor cell behaviors in embryonic day 15.5 (E16.5) Itgb1ΔEndo/ΔEndo (Ngn3Cre; Itgb1f/f; Rosa26mT/mG) embryonic pancreas explants.

Ctnna1-mediated cell-cell adhesion is required for normal islet morphology and endocrine cell aggregation.

Figure 3—source data 1

Figure 3—source data 2

Figure 3—source data 3

Ctnna1 is required for proper islet functionality and α-cell survival.

Figure 4—source data 1

Figure 4—source data 2

Figure 4—source data 3

Figure 4—source data 4

Figure 4—source data 5

Figure 4—source data 6

Figure 4—source data 7

Figure 4—source data 8

Figure 4—source data 9

Loss of Ctnna1 in α- and β-cells leads to disrupted islet architecture.

Figure 5—source data 1

Figure 5—source data 2

Disruption of cell-extracellular matrix (ECM) and/or cell-cell adhesion results in abnormal islet vascular architecture, endocrine cell aggregation, and decreased expression of β-cell maturation markers at postnatal day 7.

Abnormal islet aggregation, mis-regulation of β-cell maturation markers, and insulin secretion defects persist in Ctnna1; Itgb1ΔEndo/ΔEndo mice into adulthood.

Figure 7—source data 1

Figure 7—source data 2

Author details

Wilma Tixi

Contribution

Contributed equally with

Competing interests

Maricela Maldonado

Contribution

Contributed equally with

Competing interests

Ya-Ting Chang

Contribution

Contributed equally with

Competing interests

Amy Chiu

Contribution

Competing interests

Wilson Yeung

Contribution

Competing interests

Nazia Parveen

Contribution

Competing interests

Michael S Nelson

Contribution

Competing interests

Ryan Hart

Contribution

Competing interests

Shihao Wang

Contribution

Competing interests

Wu Jih Hsu

Contribution

Competing interests

Patrick Fueger

Contribution

Competing interests

Janel L Kopp

Contribution

Competing interests

Mark O Huising

Contribution

Competing interests

Sangeeta Dhawan

Three-dimensional (3D) segmentation analysis on whole-mount immunofluorescence images of embryonic day 15.5 (E15.5) control and Itgb1^{ΔEndo/ΔEndo} pancreata.

Time-lapse confocal microscope imaging of endocrine progenitor cell behaviors in embryonic day 15.5 (E16.5) control (Ngn3Cre; Rosa26^mT/mG) embryonic pancreas explants.

Time-lapse confocal microscope imaging of endocrine progenitor cell behaviors in embryonic day 15.5 (E16.5) Itgb1^{ΔEndo/ΔEndo} (Ngn3Cre; Itgb1^f/f; Rosa26^mT/mG) embryonic pancreas explants.

Abnormal islet aggregation, mis-regulation of β-cell maturation markers, and insulin secretion defects persist in Ctnna1; Itgb1^{ΔEndo/ΔEndo} mice into adulthood.